BridgeBio's genetic muscle disorder drug meets all goals in late-stage trial - TradingView

Reuters | Oct. 27, 2025, 7:14 a.m. | Original
BridgeBio's genetic muscle disorder drug meets all goals in late-stage trial TradingView
Angola challenges Botswana in bid for De Beers’ majority stake - Reuters Annual 2026 gold price forecast tops $4,000/oz for first time - Reuters